Larry E. Robinson, PhD, vice president of scientific affairs at Embria Health Sciences, is responsible for the ongoing research and scientific studies of existing products as well as the research and development of potential new products. He will ensure that all Embria products are backed by solid science, proven efficacious, and adhere to the strict quality standards that Embria is known for providing.

Dr. Robinson brings to Embria over 25 years of experience in the nutraceutical, pharmaceutical, and food ingredient industries. His background includes leading all phases of product R&D from planning through scale-up and commercialization. Previously, he was vice president of scientific affairs for Zila Nutraceuticals, Inc., where he led efforts developing Ester-E, and conducted all phases of research for Ester products. He also has expertise in microbiology, fermentation, enzymology, biotechnology, and business development. Larry's scientific background, combined with his experience in regulatory affairs, commercialization and marketing, make him ideally suited to lead Embria's technical efforts.

Larry earned a bachelor's degree with double majors in biology and psychology, a master of science degree in microbiology with a minor in biochemistry from Auburn University, and a Ph.D. degree in microbiology from Rutgers University, followed by post-doctoral studies at the University of Minnesota.